Concepedia

Publication | Closed Access

Treatment of Patients With Metastatic Melanoma With Autologous Tumor-Infiltrating Lymphocytes and Interleukin 2

DOI

1K

Citations

0

References

1994

Year

Steven A. Rosenberg, John R. Yannelli, James Chih‐Hsin Yang, Suzanne L. Topalian, Douglas J. Schwartzentruber, Jeffrey S. Weber, David Parkinson, Claudia A. Seipp, Jan Einhorn, Donald E. White
JNCI Journal of the National Cancer Institute

Abstract

Treatment with TILs and IL-2 with or without cyclophosphamide can result in objective responses in about one third of patients with metastatic melanoma. The side effects of treatment are transient in most patients, and this treatment can be safely administered. These results illustrate the potential value of immune lymphocytes for the treatment of patients with melanoma.